Clinical Trial Update: AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease [NA]

View source ↗

Summary

A clinical trial is planned to develop an AI-based frailty risk prediction tool for adults with congenital heart disease, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Adult Congenital Heart Disease, Symptom Clusters | NA | Status: NOT_YET_RECRUITING